Buscar
Mostrando ítems 1-10 de 46
Sclerostin And Insulin Resistance In Prediabetes: Evidence Of A Cross Talk Between Bone And Glucose Metabolism
(AMER DIABETES ASSOCALEXANDRIA, 2015)
Circulating Sclerostin in Disorders of Parathyroid Gland Function
(Endocrine Soc, 2011-12-01)
Context: Sclerostin, a protein encoded by the SOST gene in osteocytes and an antagonist of the Wnt signaling pathway, is down-regulated by PTH administration. Disorders of parathyroid function are useful clinical settings ...
Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
(2012)
Abstract
Introduction
Sclerostin levels have been reported to be low in ankylosing spondylitis (AS), but there is no data ...
Serum sclerostin is an independent predictor of mortality in hemodialysis patients
(BMC, 2014-12-02)
Background
Sclerostin (Scl) has recently emerged as a novel marker of bone remodeling and vascular calcification. However, whether high circulating Scl is also a risk factor for death is not well established. ...
Expression of Fibroblast Growth Factor 23, Vitamin D Receptor, and Sclerostin in Bone Tissue from Hypercalciuric Stone Formers
(Amer Soc Nephrology, 2014-07-07)
Background and objectives Increased bone resorption, low bone formation, and abnormal mineralization have been described in stone formers with idiopathic hypercalciuria. It has been previously shown that the receptor ...
CKD-MBD: from the Pathogenesis to the Identification and Development of Potential Novel Therapeutic Targets
(2018-12-01)
Purpose of Review: Although we have seen tremendous advances in the comprehension of CKD-MBD pathophysiology during the last few years, this was not accompanied by a significant change in mortality rate and quality of life. ...
Validation and comparison of two commercially available ELISAs for circulating sclerostin
(Elsevier B.V., 2012-05-01)
Serum sclerostin is an independent predictor of mortality in hemodialysis patients
(2014-12-02)
Abstract
Background
Sclerostin (Scl) has recently emerged as a novel marker of bone remodeling and vascular calcification. However, whether high circulating Scl is also a risk ...
Peritoneal dialysis per se is a risk factor for sclerostin-associated adynamic bone disease
(Nature Publishing Group, 2015-05-01)
Chronic kidney disease-mineral bone disorder (CKD-MBD) is a complex syndrome influenced by various factors, such as age, CKD etiology, uremic toxins, and dialysis modality. Although extensively studied in hemodialysis (HD) ...